CVE-2018-18630 : What You Need to Know

A security weakness has been discovered in versions 13.x and 14.x of the McKesson Cardiology product, potentially allowing unauthorized code execution.

Understanding CVE-2018-18630

A vulnerability in McKesson Cardiology product versions 13.x and 14.x could lead to arbitrary code execution by an attacker with local system access.

What is CVE-2018-18630?

The vulnerability arises from incorrect file permissions in the default setup of the affected versions, enabling unauthorized code execution.

The Impact of CVE-2018-18630

The vulnerability could allow an attacker with local system access to execute arbitrary code, posing a significant security risk to affected systems.

Technical Details of CVE-2018-18630

The technical aspects of the vulnerability are as follows:

Vulnerability Description

Insecure file permissions in the default installation of McKesson Cardiology product versions 13.x and 14.x may permit unauthorized code execution.

Affected Systems and Versions

Product: McKesson Cardiology
Versions: 13.x and 14.x

Exploitation Mechanism

The vulnerability can be exploited by an attacker with local system access to execute arbitrary code, potentially leading to system compromise.

Mitigation and Prevention

To address CVE-2018-18630, consider the following steps:

Immediate Steps to Take

Apply security patches provided by the vendor promptly.
Restrict access to vulnerable systems to authorized personnel only.
Monitor system logs for any suspicious activities.

Long-Term Security Practices

Regularly update and patch all software and applications.
Implement the principle of least privilege to restrict unnecessary access.
Conduct regular security audits and assessments to identify and mitigate vulnerabilities.

Patching and Updates

Stay informed about security updates and patches released by McKesson for the Cardiology product.
Ensure timely application of patches to mitigate the vulnerability effectively.